Abstract
In the past decade new indications for cardiac pacing have emerged. Remarkably, most of these conditions are not associated with bradycardia1-4. New indications include marked first-degree AV block, malignant vasovagal syncope, obstructive hypertrophic cardiomyopathy, end-stage dilated cardiomyopathy (poor systolic left ventricular function) with congestive heart failure, and paroxysmal atrial fibrillation. Pacemaker technology has continued to advance rapidly in many directions (Table 1) and has also focused on the development of systems to provide optimal pacing in many of the patients with the new indications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
